EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudie

Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial

Andrei M Darie iD, Leticia Grize, Kathleen Jahn, Anna Salina, Jonathan Röcken, Matthias J Herrmann, Maria Pascarella, Vivian Suarez, Werner Strobel, Michael Tamm, Daiana Stolz iD

European Respiratory Journal · 2025

DOI: 10.1183/13993003.01586-2024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Respiratory Journal, 2025. Verfasst von Andrei M Darie und 10 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Bronchoscopy, Hypoxia, Oxygen, Oxygen Inhalation Therapy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients with COPD are at increased risk for developing additional respiratory comorbidities associated with smoking, and are thus prone to undergo flexible bronchoscopy. However, COPD patients have increased periprocedural complications risk and lower oxygen saturation during bronchoscopy.

Methods

This was an investigator-initiated, single-centre, open-label randomised controlled trial designed to assess the benefits of high-flow nasal oxygen compared to conventional low-flow oxygen by nasal cannula during conscious sedation for bronchoscopy in patients with COPD. Low flow was supplied at a starting rate of 4 L·min −1 and gradually increased up to 12 L·min −1 to maintain peripheral oxygen saturation ( S pO 2 ) >90%. High flow delivered starting at a rate of 60 L·min −1 and an inspiratory oxygen fraction of 0.6 was increased up to 80 L·min −1 to preserve S pO 2 >90%. The primary end-point was cumulative hypoxaemia time.

Results

We randomised 600 COPD cases with a median (interquartile range (IQR)) age of 69.0 (62.0–76.0) years to either high flow (n=295) or low flow (n=305). The cumulative hypoxaemia time was 53% lower in the high-flow group (1.8% (95% CI 1.5–2.2%) versus 3.8% (95% CI 3.2–4.5%) of monitoring time; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BronchoscopyHypoxiaOxygenOxygen Inhalation TherapyPulmonary Disease, Chronic ObstructiveAgedFemaleHumansMaleMiddle AgedCannulaOxygen Saturation

Substanzen

Oxygen

Autor:innen und Institutionen

  • Clinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland.
  • Clinic of Respiratory Medicine, University of Freiburg, Freiburg, Germany.
  • Riga Stradins University, Riga, Latvia.
  • Riga East University Hospital, Riga, Latvia.
  • Department of Emergency Medicine, University Hospital Basel, Basel, Switzerland.
  • Clinic of Respiratory Medicine, University of Freiburg, Freiburg, Germany Daiana.Stolz@uniklinik-freiburg.de.

ORCID-Profile: Andrei M Darie, Daiana Stolz

Zitieren

APA

Darie, A. M., Grize, L., Jahn, K., Salina, A., Röcken, J., Herrmann, M. J., Pascarella, M., Suarez, V., Strobel, W., Tamm, M., & Stolz, D. (2025). Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial. European Respiratory Journal. https://doi.org/10.1183/13993003.01586-2024

Vancouver

Darie AM, Grize L, Jahn K, Salina A, Röcken J, Herrmann MJ, et al. Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial. European Respiratory Journal. 2025. doi:10.1183/13993003.01586-2024

BibTeX
@article{Darie2025,
  author = {Darie, Andrei M and Grize, Leticia and Jahn, Kathleen and Salina, Anna and Röcken, Jonathan and Herrmann, Matthias J and Pascarella, Maria and Suarez, Vivian and Strobel, Werner and Tamm, Michael and Stolz, Daiana},
  title = {Preventing oxygen desaturation during bronchoscopy in COPD patients using high-flow oxygen versus standard management: the randomised controlled PROSA 2 trial},
  journal = {European Respiratory Journal},
  year = {2025},
  doi = {10.1183/13993003.01586-2024}
}
Kostenlos starten →